Markus Malmberg1, Jarmo Gunn1, Päivi Rautava2,3, Jussi Sipilä4,5, Ville Kytö6,7. 1. Heart Center, Turku University Hospital and University of Turku, Turku, Finland. 2. Department of Public Health, University of Turku, Turku, Finland. 3. Turku Clinical Research Centre, Turku University Hospital, Turku, Finland. 4. Department of Neurology, North Karelia Central Hospital, Siun Sote, Joensuu, Finland. 5. Department of Neurology, University of Turku, Turku, Finland. 6. Center for Population Health Research, Turku University Hospital and University of Turku, Turku, Finland. 7. Administative Center, Hospital District of Southwest Finland, Turku, Finland.
Abstract
OBJECTIVE: To study the long-term outcome differences between acute myocardial infarction (MI) and stable coronary artery disease (CAD) patients treated with coronary artery bypass grafting (CABG). METHODS: We studied retrospectively patients with MI (n = 1882) or stable CAD (n = 13117) treated with isolated CABG between 2004 and 2014. Inverse propensity probability weight adjustment for baseline features was used. Median follow-up was 7.9 years. RESULTS: In-hospital mortality (8.6% vs. 1.6%; OR 5.94; p < .0001) and re-sternotomy (5.5% vs. 2.7%; OR 2.07; p < .0001) were more common in MI patients compared to stable CAD patients. Hospital surviving MI patients had higher all-cause mortality (28.2% vs. 22.2%; HR 1.37; p = .002) and MACE rate (34.4% vs. 27.4%; HR 1.22; CI 1.00-1.50; p = .049) at 10-year follow-up. Cardiovascular mortality (15.9% vs. 12.7%; HR 1.36; p = .017) and rate of new myocardial infarction (12.0% vs. 9.8%; HR 1.40; p = .034) were also higher in MI patients during follow-up. In follow-up of stabilized first-year survivors, the difference in all-cause (26.5% vs. 20.7%; HR 1.40; p = .003) and cardiovascular (14.2% vs. 11.4%; HR 1.37; p = .027) mortality continued to increase between MI and stable CAD patients. CONCLUSION: MI patients have poorer short- and long-term outcomes compared to stable CAD patients after CABG and risk difference continues to increase with time. Key Messages Patients with myocardial infarction have poorer short- and long-term outcomes compared to stable coronary artery disease patients after coronary artery bypass grafting (CABG). Higher risk of death continues also in stabilized first-year myocardial infarct survivors. The importance of efficient secondary prevention and follow-up highlights in post-myocardial infarct population after CABG.
OBJECTIVE: To study the long-term outcome differences between acute myocardial infarction (MI) and stable coronary artery disease (CAD) patients treated with coronary artery bypass grafting (CABG). METHODS: We studied retrospectively patients with MI (n = 1882) or stable CAD (n = 13117) treated with isolated CABG between 2004 and 2014. Inverse propensity probability weight adjustment for baseline features was used. Median follow-up was 7.9 years. RESULTS: In-hospital mortality (8.6% vs. 1.6%; OR 5.94; p < .0001) and re-sternotomy (5.5% vs. 2.7%; OR 2.07; p < .0001) were more common in MI patients compared to stable CAD patients. Hospital surviving MI patients had higher all-cause mortality (28.2% vs. 22.2%; HR 1.37; p = .002) and MACE rate (34.4% vs. 27.4%; HR 1.22; CI 1.00-1.50; p = .049) at 10-year follow-up. Cardiovascular mortality (15.9% vs. 12.7%; HR 1.36; p = .017) and rate of new myocardial infarction (12.0% vs. 9.8%; HR 1.40; p = .034) were also higher in MI patients during follow-up. In follow-up of stabilized first-year survivors, the difference in all-cause (26.5% vs. 20.7%; HR 1.40; p = .003) and cardiovascular (14.2% vs. 11.4%; HR 1.37; p = .027) mortality continued to increase between MI and stable CAD patients. CONCLUSION: MI patients have poorer short- and long-term outcomes compared to stable CAD patients after CABG and risk difference continues to increase with time. Key Messages Patients with myocardial infarction have poorer short- and long-term outcomes compared to stable coronary artery diseasepatients after coronary artery bypass grafting (CABG). Higher risk of death continues also in stabilized first-year myocardial infarct survivors. The importance of efficient secondary prevention and follow-up highlights in post-myocardial infarct population after CABG.
Authors: Franz-Josef Neumann; Miguel Sousa-Uva; Anders Ahlsson; Fernando Alfonso; Adrian P Banning; Umberto Benedetto; Robert A Byrne; Jean-Philippe Collet; Volkmar Falk; Stuart J Head; Peter Jüni; Adnan Kastrati; Akos Koller; Steen D Kristensen; Josef Niebauer; Dimitrios J Richter; Petar M Seferovic; Dirk Sibbing; Giulio G Stefanini; Stephan Windecker; Rashmi Yadav; Michael O Zembala Journal: Eur Heart J Date: 2019-01-07 Impact factor: 29.983
Authors: Pedro Freitas; Márcio Madeira; Luís Raposo; Sérgio Madeira; João Brito; Catarina Brízido; Francisco Gama; Nélson Vale; Sara Ranchordás; Pedro Magro; Ana Braga; Pedro de Araújo Gonçalves; Henrique Mesquita Gabriel; Tiago Nolasco; Sérgio Boshoff; Marta Marques; Luís Bruges; José Calquinha; Miguel Sousa-Uva; Miguel Abecasis; Manuel Almeida; José Pedro Neves; Miguel Mendes Journal: Am J Cardiol Date: 2018-12-03 Impact factor: 2.778
Authors: Christian Puelacher; Mathias Gugala; Philip D Adamson; Nicholas L Mills; Christian Mueller; Anoop Shah; Andrew R Chapman; Atul Anand; Zaid Sabti; Jasper Boeddinghaus; Thomas Nestelberger; Raphael Twerenbold; Karin Wildi; Patrick Badertscher; Maria Rubini Gimenez; Samyut Shrestha; Lorraine Sazgary; Deborah Mueller; Lukas Schumacher; Nikola Kozhuharov; Dayana Flores; Jeanne du Fay de Lavallaz; Oscar Miro; Francisco Javier Martín-Sánchez; Beata Morawiec; Gregor Fahrni; Stefan Osswald; Tobias Reichlin Journal: Heart Date: 2019-04-24 Impact factor: 5.994
Authors: Alexander Hirsch; Niels J W Verouden; Karel T Koch; Jan Baan; José P S Henriques; Jan J Piek; Wim J Rohling; Rene J van der Schaaf; Jan G P Tijssen; Marije M Vis; Robbert J de Winter Journal: Am J Cardiol Date: 2009-06-06 Impact factor: 2.778
Authors: Stephan Windecker; Stefan Stortecky; Giulio G Stefanini; Bruno R da Costa; Bruno R daCosta; Anne Wilhelmina Rutjes; Marcello Di Nisio; Maria G Silletta; Maria G Siletta; Ausilia Maione; Fernando Alfonso; Peter M Clemmensen; Jean-Philippe Collet; Jochen Cremer; Volkmar Falk; Gerasimos Filippatos; Christian Hamm; Stuart Head; Arie Pieter Kappetein; Adnan Kastrati; Juhani Knuuti; Ulf Landmesser; Günther Laufer; Franz-Joseph Neumann; Dimitri Richter; Patrick Schauerte; Miguel Sousa Uva; David P Taggart; Lucia Torracca; Marco Valgimigli; William Wijns; Adam Witkowski; Philippe Kolh; Peter Jüni; Peter Juni Journal: BMJ Date: 2014-06-23